Fig. 8From: Novel approaches for determination of antiretroviral reverse transcriptase inhibitor agent in commercial dosage forms by using spectrofluorimetric, first derivative spectrophotometric, and HPLC methodsUV-spectrums of the tenofovir calibration solutionsBack to article page